Purdue sues its insurers for $3.3bn of opioid litigation coverage

Purdue

Purdue Pharma has sued its insurers, seeking a ruling that it is entitled to $3.3bn of coverage under its policies to help pay some of the liability the OxyContin maker faces from thousands of opioid mass tort claims.

Want to read this article?

Subscribe for FULL access to this article - and ALL our premium content

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey
Commercial director
Email: spencer.halladey@wbmediagroup.com
Tel: +44 (0) 203 934 6687

Andy Stone
Sales manager
Email: andy.stone@wbmediagroup.com
Tel: +44 (0) 203 934 6684

Subscribers get access to:

  • Full web access to all content
  • Regular breaking news/analysis by email on all critical issues
  • Two daily round-ups of the day’s news
  • Opinion from market thought-leaders and exclusive data on the industry
  • Control over the content you receive - and WHEN you receive it
  • Access to The Insurer App
  • Discounted subscriber prices for all our events
  • Dedicated account manager to ensure you receive the best value for money 

If you are a subscriber you can SIGN IN now for FULL access